Activity of ADAM17 (a Disintegrin and Metalloprotease 17) Is Regulated by Its Noncatalytic Domains and Secondary Structure of its Substrates

ADAM proteases are implicated in multiple diseases, but no drugs based on ADAM inhibition exist. Most of the ADAM inhibitors developed to date feature zinc-binding moieties that target the active site zinc, which leads to a lack of selectivity and off target toxicity. Targeting secondary substrate b...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Stawikowska, Roma, Cudic, Mare, Giulianotti, Marc, Houghten, Richard A., Fields, Gregg B., Minond, Dmitriy
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Biochemistry and Molecular Biology 2013
נושאים:
Enzymology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3829370/
https://ncbi.nlm.nih.gov/pubmed/23779109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M113.462267
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים